PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Short Interest Update

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the recipient of a significant decrease in short interest in the month of May. As of May 29th, there was short interest totaling 8,311 shares, a decrease of 83.9% from the May 14th total of 51,769 shares. Based on an average trading volume of 266,185 shares, the short-interest ratio is presently 0.0 days.

PharmaTher Stock Performance

OTCMKTS:PHRRF traded down $0.00 during trading hours on Wednesday, reaching $0.04. The company had a trading volume of 56,490 shares, compared to its average volume of 176,071. The stock has a 50-day moving average of $0.05 and a two-hundred day moving average of $0.06. PharmaTher has a one year low of $0.04 and a one year high of $0.55.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.